Clinical Trials Logo

Renal Insufficiency, Chronic clinical trials

View clinical trials related to Renal Insufficiency, Chronic.

Filter by:

NCT ID: NCT02787161 Completed - Clinical trials for Chronic Kidney Disease

Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes

HDFIT
Start date: August 2016
Phase: N/A
Study type: Interventional

This is a randomized controlled clinical trial that will analyze the impact of high volume online HDF in comparison to high-flux HD on measured physical activity.

NCT ID: NCT02786849 Recruiting - Clinical trials for Chronic Kidney Diseases

Neuromuscular Electrical Stimulation During Hemodialysis in Peripheral Muscle Strength and Exercise Capacity

Start date: June 2015
Phase: N/A
Study type: Interventional

The objective of this study will be to evaluate the effects of neuromuscular electrical stimulation of high and low frequency and intensity, performed during hemodialysis (HD), on peripheral muscle strength, exercise capacity and muscle change and inflammation markers in patients with chronic kidney disease (CKD).

NCT ID: NCT02780726 Completed - Clinical trials for Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

Start date: June 22, 2016
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of ASP1517 in peritoneal dialysis chronic kidney disease patients with anemia.

NCT ID: NCT02780141 Completed - Clinical trials for ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia

A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Start date: June 2, 2016
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and efficacy of ASP1517 in ESA-naive hemodialysis chronic kidney disease patients with anemia.

NCT ID: NCT02779764 Completed - Clinical trials for Hemodialysis Patients With Renal Anemia

A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) Treatment

Start date: May 16, 2016
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of ASP1517 in hemodialysis patients with renal anemia whose treatment is converted from an Erythropoieses Stimulating Agent formulation.

NCT ID: NCT02778295 Withdrawn - Clinical trials for Chronic Kidney Disease

Biomarker for Patients With Fabry Disease (BioFabry)

BioFabry
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrography-based biomarker for the early and sensitive diagnosis of Fabry disease from the blood

NCT ID: NCT02778269 Completed - Diabetes Clinical Trials

Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study

HypoArrhythmia
Start date: June 2016
Phase: N/A
Study type: Interventional

Patients with insulin-dependent diabetes mellitus (DM) and chronic kidney disease (CKD) exhibit an excessive risk for cardiac arrhythmias, in particular sudden cardiac death (SCD). Various studies have shown that hypoglycemic episodes are strong predictors of cardiovascular mortality in both type 1 and type 2 diabetic patients. Experimental data and small clinical studies link hypoglycemia with ECG changes and SCD, but little is known about the direct association of hypoglycemic events and/or rapid swings in blood glucose with arrhythmias in this high risk population. Ideally, an algorithm should help to identify patients at risk for hypoglycemia-associated arrhythmias and SCD, but hitherto systematic analyses of blood glucose values and 12-channel ECGs are lacking in these patients. In this validation study a 12-lead ECG T-shirt consisting of textile electrodes and a data logging device wich can record long-term 12-lead ECG data will be tested. The purpose of the T-shirt is to improve the patient's comfort for long-term recordings and to prevent adverse effects of regular ECG electrodes. Current systems are limited by the use of ECG electrodes involving disadvantages like severe direct side effects on the skin such as rash and bullous lesions as well as slipping electrodes. By the means of the proposed ECG T-shirt those drawbacks will be avoided.

NCT ID: NCT02775305 Active, not recruiting - Clinical trials for Chronic Kidney Disease

The Effects of Frailty on Chronic Kidney Disease

Start date: October 2013
Phase: N/A
Study type: Interventional

Frailty is a syndrome characterized by decreased reserve and diminished resistance to stressors. The proposed research will evaluate the association of frailty with chronic kidney disease (CKD). The prevalence of frailty increases with age and with CKD, but studies are needed to determine whether frailty is associated with worsening of CKD and whether intervention to treat frailty can improve physical functioning and health-related quality of life (HRQOL) as well as slow progression of CKD.

NCT ID: NCT02766036 Completed - Clinical trials for Chronic Kidney Diseases

Propolis Effects in Patients With Chronic Kidney Disease

Start date: December 1, 2016
Phase: Phase 2
Study type: Interventional

The aim of this study is to determine the impact of Propolis on proteinuria reduction and protection of the glomerular filtration rate in chronic renal failure patients.

NCT ID: NCT02756520 Completed - Clinical trials for Chronic Kidney Disease

Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)

Start date: September 2016
Phase:
Study type: Observational

The purpose of this study is to characterize the patient and disease profile under the influence of a protein-restricted diet supplemented with keto acids/amino acids (KA/AA), focusing on the progression of chronic renal insufficiency, calcium and phosphorus metabolism, nutritional status, patient compliance to diet and Ketosteril intake as well as the persistent dietary education to ensure compliance in a large group of pre-dialysis patients.